The schedule presented here is subject to change as the agenda is finalized.
This schedule is preliminary and subject to change.
This presentation will share key outcomes, implementation strategies, lessons learned, and future adaptations aimed at reducing barriers and promoting employment equity for TGNC youth. Us Helping Us is also exploring opportunities to expand the program and its impact.
Using Oregon’s All-Payer All-Claims dataset (2016–2023), this analysis examines GAC utilization among transgender and gender-diverse adolescents, identifying disparities by insurance type, age, and sex assigned at birth—even within one of the nation’s most affirming policy environments. Quantitative findings are contextualized with lived experience: the journey of raising a ten-year-old transgender son, illustrating, through narrative and video excerpts, how timely, evidence-based, and affirming care fosters gender euphoria, confidence, safety, and family cohesion.
Having previously reported on clinical outcomes of Adolescents and Young Adults with HIV (AYAHIV) in the Accessing Care Early (ACE) young adult transition program, we present an update, detailing the design and implementation of this multi-dimensional program, the innovations in biomedical and care delivery interventions, as well as programmatic challenges and opportunities as we evolve into a mature transition program. This workshop will use didactics and interactive presentation, case-study, transparent panel discussion and Q&A as participants engage with the ACE program’s multidisciplinary team, including an YAHIV who “came of age” in the program.
With advancements in HIV treatment, individuals living with HIV are now living longer, By 2030, 70% of people living with HIV (PLWH) will be ages 50 and older. But, as PLWH age they face unique challenges, particularly with cognitive health. One major concern is HIV-Associated Neurocognitive Disorder (HAND), a form of cognitive decline more common among PLWH. This presentation will provide a brief overview of HIV care; the signs and risk factors for HAND; similarities and differences between HAND and Alzheimer's disease; and why accurately diagnosing cognitive change in PLWH is so important.
This presentation will explore critical considerations in the management of HIV in the context of pregnancy, focusing on evidence-based practices and clinical guidelines. Divided into three clinically relevant scenarios, the session will address: (1) treatment and monitoring of HIV in pregnant individuals, (2) postnatal management of infants with in utero exposure to HIV, and (3) considerations for HIV-positive parents who plan to breastfeed. Each topic will be anchored by a clinical case, offering participants an opportunity to apply current guidelines. Emphasis will be placed on reducing risk of perinatal HIV transmission, optimizing maternal and infant outcomes, and navigating ethical and cultural factors in decision making. Attendees will leave with practical clinical pearls and an updated understanding of best practices in HIV care during pregnancy and the postpartum period.
In recent years, sexually transmitted infections (STI) rates in the United States have risen dramatically, with more than 2.4 million STIs reported in the United States alone (CDC, 2024). STIs can have a profound impact on health, including infertility, neurological and cardiovascular disease, stillbirths, and increased risk of Human Immunodeficiency Virus (HIV). This growing epidemic demands urgent action to enhance the prevention, diagnosis, and treatment of STIs.
Sexually Transmitted Infections (STIs) are a growing public health concern, particularly for women and girls, who experience disproportionately high rates and rising incidence. Barriers such as cost, transportation and geographic access, and appointment availability limit access to timely STI care. For those who do access family planning care, integrating STI testing into comprehensive visits can reduce the need for repeat appointments and improve health and wellbeing.
In 2023, in response to rising syphilis rates and persistent disparities in STI outcomes, we launched a free, community-based STI clinic to expand access to testing and treatment. Prior to this, our services were primarily focused on providing PrEP and HIV care to the LGBT population. In 2024 alone, the clinic served 871 patients—69% of whom identified as ethnic minorities, a population disproportionately impacted by barriers to healthcare access, including PrEP.
Despite the wide availability of antiretroviral therapy (ART) as an effective treatment option for HIV, a substantial portion of people with HIV (PWH) in the United States remain out of care or inconsistently take their medications, leading to an unsuppressed viral load despite diagnosis—a critical gap that undermines both individual health outcomes and public health objectives.
Information on credits offered to SYNC participants for attending institutes, sessions, and plenaries — live or in-person — is available here.
This conference is supported, in part, by independent educational grants from ineligible companies. A full list of supporters is available here. All accredited content has been developed and delivered in accordance with the ACCME Standards for Integrity and Independence and the criteria of Joint Accreditation for Interprofessional Continuing Education™, and is free of commercial bias.
We have received reports that companies are reaching out to sell SYNChronicity Conference attendee lists and other potential services. This is a scam and these companies are not affiliated with SYNChronicity, HealthHIV, HealthHCV, or the National Coalition for LGBTQ Health. Do not engage with them. Please contact us directly with any questions.